Ardelyx Inc. sell mixitrader
Start price
04.03.23
/
50%
€3.66
Target price
04.03.24
€1.00
Performance (%)
3.26%
End price
30.09.23
€3.78
Summary
This prediction ended on 30.09.23 with a price of €3.78. The SELL prediction by mixitrader shows the price for Ardelyx Inc. slightly increased by 3.26% during the runtime of the prediction. mixitrader has 50% into this predictionArdelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ardelyx Inc. | -1.640% | -1.640% | 48.049% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |